■CD163‐positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma

Eri Matsubara ,Yoshihiro Komohara ,Yusuke Shinchi ,Remi Mito , Yukio Fujiwara , Koei Ikeda , Toshiyuki Shima , Masayuki Shimoda5 , Yae Kanai , Takuro Sakagami , Makoto Suzuki

Pathology InternationalVolume 71, Issue 10 p. 666-673

■ Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.

Mito R, Matsubara E, Komohara Y, Shinchi Y, Sato K, Yoshii D, Ohnishi K, Fujiwara Y, Tomita Y, Ikeda K, Sakagami T, Suzuki M.

Pathol Int 70: 287-294, 2020.

■Long-term follow-up of ciliated muconodular papillary tumor of the lung by computed tomography: a case report

Ryohei Matsushima, Takeshi Mori, Sho Saeki, Hironori Hinokuma, Hidekazu Tanaka, and  Hiroshi Yokomizo

J Surg Case Rep. 2020 Dec; 2020(12)

■Endobronchial Ultrasound-Guided Radiofrequency Ablation of Lung Tumors and Mediastinal Lymph
Nodes: A Preclinical Study in Animal Lung Tumor and Mediastinal Adenopathy Models.

Motooka Y, Fujino K, Gregor A, Bernards N, Chan H, Inage T, Ujiie H, Kato T, Kinoshita T, Ishiwata T, Suzuki M, Yasufuku K.

Semin Thorac Cardiovasc Surg. 2020 Feb 10

■Tumor cell-derived angiopoietin-like protein 2 establishes a preference
for glycolytic metabolism in lung cancer cells.

Osumi H, Horiguchi H, Kadomatsu T, Tashiro K, Morinaga J, Takahashi T, Ikeda K, Ito T, Suzuki M, Oike Y.

Cancer Sci. 2020 Apr;111(4):1241-1253.

■Surgical treatment of synchronous multiple lung adenocarcinomas: experiment of 171 cases.

Ikeda K, Fujino K, Masuda Y, Suzuki M.

Journal of Visualized Surgery. 2020;6(I):15-15. doi:10.21037/jovs.2019.12.07

■Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.

Mito R, Matsubara E, Komohara Y, Shinchi Y, Sato K, Yoshii D, Ohnishi K, Fujiwara Y, Tomita Y, Ikeda K, Sakagami T, Suzuki M.

Pathol Int   2020;1–8

■Significance of Tsukushi in lung cancer.

Yamada T, Ohta K, Motooka Y, Fujino K, Kudoh S, Tenjin Y, Sato Y, Matsuo A, Ikeda K, Suzuki M, Ito T.

Lung Cancer 2019 May;131:104-111.

■First Evaluation of the Next-Generation Endobronchial Ultrasound System in Preclinical Models.

Fujino K, Ujiie H, Kinoshita T, Lee CY, Igai H, Inage T, Motooka Y, Gregor A, Suzuki M, Yasufuku K. Mori T., Suzuki M.

Ann Thorac Surg. 2019 May;107(5):1464-1471.

■Long-Term Prognosis After Segmentectomy for cT1 N0 M0 Non-Small Cell Lung Cancer. Ann Thorac Surg.

Nomori H, Mori T, Shiraishi A, Fujino K, Sato Y, Ito T, Suzuki M.

2019 May;107(5):1500-1506.

■Accurate expression of PD-L1/L2 in lung adenocarcinoma cells: a retrospective study
by double immunohistochemistry.

Shinchi Y, Komohara Y, Yonemitsu K, Sato K, Ohnishi K, Saito Y, Fujiwara, Y, Mori T, Shiraishi K, Ikeda K, Suzuki M.

Cancer sci 110: 2711-2721, 2019. 

■Pathobiology of Notch2 in lung cancer.

Motooka Y, Fujino K, Sato Y, Kudoh S, Suzuki M, Ito T.

Pathology. 2017;49(5):486-93.

■INSM1 is the Best Marker for the Diagnosis of Neuroendocrine
Tumors:Comparison with CGA, SYP and CD56

Fujino K, Yasufuku K, Kudoh S, Motooka Y, Sato Y, Wakimoto J, Suzuki M, Ito T
Int J Exp Pathol. 2017 In Press

■Synchronous Multiple Lung Adenocarcinomas: Estrogen Concentration in Peripheral Lung.

Ikeda K.*, Shiraishi K., Yoshida A., Shinchi Y., Sanada M., Motooka Y., Fujino K.,

Mori T., Suzuki M.

PLoS One. 11 (2016) [IF, 3.057; citation, 0]

■Pulmonary hepatoid adenocarcinoma: report of a case.

Motooka Y, Yoshimoto K, Semba T, Ikeda K, Mori T, Honda Y, Iyama K, Suzuki M

Surg Case Rep.

2016 Dec;2(1):1. doi: 10.1186/s40792-016-0129-6. Epub 2016 Jan 8.

■Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer.

Fujino K, Motooka Y, Hassan WA, Ali Abdalla MO, Sato Y, Kudoh S, Hasegawa K, Niimori-Kita K, Kobayashi H, Kubota I, Wakimoto J, Suzuki M, Ito T.

Am J Pathol. 2015 Dec;185(12):3164-77. doi:

10.1016/j.ajpath.2015.08.018. Epub 2015 Oct 23. PubMed PMID: 26482608.

■Novel approach to pleurodesis with 50 % glucose for air leakage after lung resection or pneumothorax.

Fujino K, Motooka Y, Koga T, Osumi H, Matsubara E, Shibata H, Ikeda K, Shiraishi K, Mori T, Hayashi K, Yoshimoto K, Wakimoto J, Kubota I, Suzuki M

Surg Today. 2015 Jul 24.

■Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma.

Ikeda K, Shiraishi K, Koga T, Motooka Y, Fujino K, Shibata H, Mori T,Suzuki M.

Ann Thorac Surg. 2015 Mar 28

■Interstitial Fluid Pressure Correlates Clinicopathological Factors of Lung Cancer.

Mori T, Koga T, Shibata H, Ikeda K, Shiraishi K, Suzuki M, Iyama KI.

Ann Thorac Cardiovasc Surg. 2015 Jan 26

■Metastasectomy of Pulmonary Metastases from Osteosarcoma: Prognostic Factors and Indication for Repeat Metastasectomy

Matsubara E, Mori T, Koga T, Shibata H, Ikeda K, Shiraishi K, Suzuki M

Respir Med 2015

■Association of a Genetic Variant of CYP19A1 with Multicentric Development of Lung Adenocarcinomas

Ikeda K, Shiraishi K, Eguchi A, Osumi H, Matsuishi K, Matsubara E, Fujino K, Shibata H, Yoshimoto K, Mori T, Omori H, Suzuki M..

Ann Surg Oncol. 2014 Mar;21(3):939-45.

■Multipile Lung Adenocarcinomas Associated With Von Hippel-Lindau Disease

Ikeda K, Osumi H, Matsuishi K, Matsubara E, Fujino K, Shibata H, Yshimoto K, Shiraishi K, Mori T, Suzuki M

Ann Thorac Surg 2014;98:1467-1470

■Long Interspesed Nucleotide Element 1 Hypomethylation IsAssociatedWith Poor Prognosis of Lung Adenocarcinoma

Ikeda K, Shiraishi K, Eguchi A, Shibata H, Yoshimoto K, Mori T, Baba T, Baba H, Suzuki M

Ann Thorac Surg 2013;96:1790-1795

■Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer.

Suzuki M, Shiraishi K, Eguchi A, Ikeda K, Mori T, Yoshimoto K, Ohba Y, Yamada T, Ito T, Baba Y, Oncology　letter Baba H. Oncol Rep. 2013 Apr;29

(4):1308-14.

■A Case of Desmoid-Type Fibromatosis Arising after Thoracotomy for Lung Cancer with a Review of the English and
Japanese Literature

Mori T, Yamada T, Ohba Y, Yoshimoto K, Ikeda K, Shiraishi K, Suzuki M.

Ann Thorac Cardiovasc Surg. 2013 Apr 5